Vaxcyte EBIT 2019-2024 | PCVX
- Vaxcyte 2023 EBIT was -0.468B, a 101.52% increase from 2022.
- Vaxcyte 2022 EBIT was -0.232B, a 124.03% increase from 2021.
- Vaxcyte 2021 EBIT was -0.104B, a 15.73% increase from 2020.
EBIT can be defined as earnings before interest and taxes.